Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositisTakashi Matsushita, K. Takehara, Momoko Tennichi et al.|British Journal of Dermatology|2016Cited by 186
OP0015 THE ROLE OF MULTI-CRITERIA DECISION ANALYSIS IN THE DEVELOPMENT OF CANDIDATE CLASSIFICATION CRITERIA FOR ANTISYNTHETASE SYNDROME: ANALYSIS FROM THE CLASS PROJECTG. Zanframundo, R. K. Aggarwal, Eduardo Dourado et al.|Annals of the Rheumatic Diseases|2024Cited by 1